Rhinoconjunctivitis Quality of Life Questionnaire

Name of Questionnaire

Rhinitis Quality of Life Questionnaire (RQLQ)

Description

A disease-specific health-related quality of life instrument developed by E. Juniper and colleagues that taps both physical and emotional impact of disease.

Developer

Juniper EF, Guyatt GH, Andersson B, Ferrie PJ ¹

Address

Elizabeth Juniper MCSP Msc
20 Marcuse Fields
Bosham, West Sussex
PO18 8NA, England
Tel: +44 1243 572124; Fax: +44 1243 573680

E-mail

juniper@qoltech.co.uk

URL

http://www.qoltech.co.uk/

Cost & availability

Yes; contact E. Juniper for permission to use the instrument

Administration

Interviewer

Time to complete

10-15 minutes

Number of items

24

Domains & categories

6 categories

Name of categories/domains

Activities, emotions, sleep, non-nasal symptoms, practical problems, nasal symptoms

Scaling of items

7-point Likert scale

Scoring

All items are weighted equally. Mean score is calculated across all items within each domain. Overall score is the mean across all items.

Reliability

Validity

Established by comparison to conventional clinical asthma measures (symptoms, peak flow rates, medication use, PFT, airway responsiveness, global rating of asthma), generic HRQL measures (Rand; SIP) ^{2 , 3} , clinical sensibility of the measure ⁶ ; symptoms & clinical efficacy ¹³

Responsiveness

Reported ^{4 , 13} ; minimal important difference determined to be 0.5. Change of 1.0 represents a moderate change; change greater than 2.0 represents large change.

Minimally important difference

Reflected by a change in score of 0.5 on a seven point scale ⁴ .

Research use

Yes, including clinical trials

Clinical use

Short version for clinical use has been developed

Language

Original: English (Canada)

Dutch

References

1. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Annals Allergy 1993; 70: 225-230.
2. Juniper Ef, Willms DG, Guyatt GH, Ferrie PJ. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. Can Med Assoc J 1992;147(6):887-92.
3. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasons dipropiionated in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol 1993;92:66-72.
4. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone dipropionate nasal spray" regular versus "as required" use in the treatment of seasonal allergic rhinitis. J Allergy Clin Imunol 1990;86:380-6.
5. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99:S742-9.   Naclerio et al., 1997
6. De Graaf-in't Veld et al., 1996 (Dutch version)
   

Date of information

May 2000